A high proportion of PD-L1-positive tumors are infiltrated with PD-1-positive lymphocytes and, more interestingly, PD-L1 is expressed not only on T cells but also on breast cancer cells, thus it can be considered as a potential co-target for breast cancer treatments26,27. Here, CD274 is linked to breast carcinoma.